Verastem, Inc. (LON:0LOV)
London · Delayed Price · Currency is GBP · Price in USD 5.97
-0.23 (-3.71%)
Feb 12, 2026, 4:19 PM GMT
Verastem Market Cap
Verastem has a market cap or net worth of 330.89 million as of February 12, 2026. Its market cap has increased by 53.96% in one year.
Market Cap
330.89M
Enterprise Value
295.48M
Revenue
9.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.97
Market Cap Chart
Since January 27, 2012, Verastem's market cap has increased from 142.97M to 330.89M, an increase of 131.43%. That is a compound annual growth rate of 6.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 358.64M | -18.99% |
| Dec 31, 2025 | 442.71M | 140.87% |
| Dec 31, 2024 | 183.80M | 13.82% |
| Dec 29, 2023 | 161.48M | 130.08% |
| Dec 30, 2022 | 70.18M | -74.56% |
| Dec 31, 2021 | 275.82M | 4.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| Craneware | 543.61M |
| Advanced Medical Solutions Group | 466.09M |
| PureTech Health | 312.74M |
| NIOX Group | 272.49M |